课题基金 / 基金详情

New understanding and targets from the human phosphatome: towards the treatment of castration-resistant prostate cancer.

New understanding and targets from the human phosphatome: towards the treatment of castration-resistant prostate cancer.
人类磷酸化组的新认识和目标:治疗去势抵抗性前列腺癌。
批准号:
366581
负责人:
Tremblay Michel L
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-11-01 至 2017-11-01

项目摘要

项目成果

Tremblay Michel L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer is the most common cancer in Canadian men. Initiation and progression of prostate cancer are complex events that are mainly induced by hormones such as androgens. For this reason, current therapies do focus on depriving androgen to tumours
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
For Improving diagnostics and grasping the disease mechanisms of rare hypomagnesemia in patients with CNNM2 mutations
  • 批准号:
    406731
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.39万
  • 财政年份:
    2019
  • 负责人:
    Tremblay Michel L
  • 依托单位:
Molecular and physiological understanding of the protein tyrosine phosphatome towards clinical applications.
  • 批准号:
    369211
  • 项目类别:
    Operating Grants
  • 资助金额:
    $219.29万
  • 财政年份:
    2017
  • 负责人:
    Tremblay Michel L
  • 依托单位:
Improving macrophage innate immunity by modulating protein tyrosine phosphatases: the complete mouse and human PTPomes
  • 批准号:
    346783
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Tremblay Michel L
  • 依托单位:
Generation of a new therapeutic approach against advanced pancreatic cancer by modulating protein tyrosine phosphatases
  • 批准号:
    341726
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.28万
  • 财政年份:
    2016
  • 负责人:
    Tremblay Michel L
  • 依托单位:
海外基金